Recent 52-Week Low Surpassed in Shares of Halozyme Therapeutics (HALO)

Halozyme Therapeutics (NASDAQ:HALO) traded today at a new 52-week low of $7.97. Approximately 1.4 million shares have changed hands today, as compared to an average 30-day volume of 1.6...